Search Results - "Kamijo, Kimimori"

A Case of Tyrosine Kinase Inhibitor-Induced Bone Marrow Aplasia That Was Successfully Treated with Allogeneic Hematopoietic Stem Cell Transplantation by Kamijo, Kimimori, Shimomura, Yoshimitsu, Yamashita, Daisuke, Ishikawa, Takayuki

“…Here, we present a rare case of tyrosine kinase inhibitor (TKI)-induced bone marrow aplasia. A 58-year-old man presented with leukocytosis and was diagnosed…”
Get full text

Clinical features and outcomes of duodenal‐type follicular lymphoma: A single‐center retrospective study by Kamijo, Kimimori, Shimomura, Yoshimitsu, Yoshioka, Satoshi, Yamashita, Daisuke, Hara, Shigeo, Ishikawa, Takayuki

“…Duodenal‐type follicular lymphoma (FL) is a rare and newly recognized disease. Few data are available on the outcomes and treatment strategies for patients…”
Get full text

Successful remission induction with reduced-dose all-trans retinoic acid for acute promyelocytic leukemia complicated by COVID-19 by Fujimoto, Rintaro, Kamae, Tsuyoshi, Kamijo, Kimimori, Yasumi, Masato, Karasuno, Takahiro

“…A 43-year-old man with pancytopenia was diagnosed with acute promyelocytic leukemia (APL). On the first day of induction therapy with all-trans retinoic acid…”
Get more information

Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation by Wada, Fumiya, Kanda, Junya, Kamijo, Kimimori, Nishikubo, Masashi, Yoshioka, Satoshi, Ishikawa, Takayuki, Ueda, Yasunori, Akasaka, Takashi, Arai, Yasuyuki, Izumi, Kiyotaka, Hirata, Hirokazu, Ikeda, Takashi, Yonezawa, Akihito, Anzai, Naoyuki, Watanabe, Mitsumasa, Imada, Kazunori, Yago, Kazuhiro, Tamura, Naoki, Itoh, Mitsuru, Masuo, Yuki, Kunitomi, Akane, Takeoka, Tomoharu, Kitano, Toshiyuki, Arima, Nobuyoshi, Hishizawa, Masakatsu, Asagoe, Kohsuke, Kondo, Tadakazu, Takaori-Kondo, Akifumi

“…Haploidentical-related donor transplantation using posttransplant cyclophosphamide (PTCy-haplo) and cord blood transplantation (CBT) are valid alternatives for…”
Get full text

Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study by Nishikubo, Masashi, Shimomura, Yoshimitsu, Maruoka, Hayato, Nasu, Seiko, Nishioka, Tomomi, Sakizono, Kenji, Mitsuyuki, Satoshi, Kubo, Tomoyo, Okada, Naoki, Nakagawa, Daishi, Kamijo, Kimimori, Imoto, Hiroharu, Yamamoto, Ryusuke, Nagai, Yuya, Hiramoto, Nobuhiro, Yoshioka, Satoshi, Yonetani, Noboru, Matsushita, Akiko, Miyakoshi, Chisato, Doi, Asako, Ishikawa, Takayuki

“…The effectiveness of mRNA COVID-19 vaccines and the optimal timing of vaccine administration in allogeneic hematopoietic stem cell transplantation (Allo-HSCT)…”
Get full text

An elderly patient with lymphoplasmacytic lymphoma successfully treated with low-dose tirabrutinib by Yasumi, Masato, Shiraishi, Kamma, Kamijo, Kimimori, Kamae, Tsuyoshi, Karasuno, Takahiro

“…A 93-year-old woman was diagnosed with lymphoplasmacytic lymphoma (LPL) with circulating tumor cells in her peripheral blood after presenting with anemia. LPL…”
Get more information

Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies by Nishikubo, Masashi, Shimomura, Yoshimitsu, Yamamoto, Ryusuke, Yoshioka, Satoshi, Maruoka, Hayato, Nasu, Seiko, Nishioka, Tomomi, Sakizono, Kenji, Mitsuyuki, Satoshi, Kubo, Tomoyo, Okada, Naoki, Nakagawa, Daishi, Kamijo, Kimimori, Imoto, Hiroharu, Nagai, Yuya, Hiramoto, Nobuhiro, Yonetani, Noboru, Kondo, Tadakazu, Miyakoshi, Chisato, Doi, Asako, Ishikawa, Takayuki

Get full text

PD‐1 expression on tumour‐infiltrating cells is a prognostic factor for relapsed or refractory diffuse large B‐cell lymphoma by Wada, Fumiya, Kamijo, Kimimori, Shimomura, Yoshimitsu, Yamashita, Daisuke, Hara, Shigeo, Ishikawa, Takayuki

“…Background The tumour microenvironment (TME), which is modulated after immune‐chemotherapy, is involved in tumour growth and metastasis. Programmed cell death…”
Get full text

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy by Kamijo, Kimimori, Shimomura, Yoshimitsu, Tachibana, Takayoshi, Najima, Yuho, Aoki, Jun, Akahoshi, Yu, Tanaka, Masatsugu, Doki, Noriko, Uchida, Naoyuki, Ohigashi, Hiroyuki, Kobayashi, Hikaru, Ota, Shuichi, Nara, Miho, Fujiwara, Shinichiro, Mori, Yasuo, Kanda, Yoshinobu, Ichinohe, Tatsuo, Atsuta, Yoshiko, Arai, Yasuyuki

“…Background Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative treatment option frequently used in patients with acute lymphoblastic…”
Get full text

Prognostic impact of CD38 expression in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma transformation by Wada, Fumiya, Shimomura, Yoshimitsu, Kamijo, Kimimori, Yamashita, Daisuke, Ohno, Aya, Himeno, Mayuko, Maruoka, Hayato, Hara, Shigeo, Ishikawa, Takayuki

Get full text

Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation by Kamijo, Kimimori, Shimomura, Yoshimitsu, Kim, Sung-Won, Ara, Takahide, Ishikawa, Jun, Eto, Tetsuya, Hiramoto, Nobuhiro, Mizuno, Ishikazu, Kusumoto, Shigeru, Ueda, Yasunori, Matsuoka, Ken-ichi, Onizuka, Makoto, Fukuda, Takahiro, Atsuta, Yoshiko, Kondo, Eisei

Get full text

Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies by Nishikubo, Masashi, Shimomura, Yoshimitsu, Yamamoto, Ryusuke, Maruoka, Hayato, Nasu, Seiko, Nishioka, Tomomi, Sakizono, Kenji, Mitsuyuki, Satoshi, Kubo, Tomoyo, Okada, Naoki, Nakagawa, Daishi, Kamijo, Kimimori, Imoto, Hiroharu, Nagai, Yuya, Hiramoto, Nobuhiro, Yoshioka, Satoshi, Yonetani, Noboru, Kondo, Tadakazu, Ishikawa, Takayuki

Get full text

Efficacy of letermovir in HLA-haploidentical hematopoietic transplantation with posttransplant cyclophosphamide by Nakagawa, Daishi, Shimomura, Yoshimitsu, Mitsuyuki, Satoshi, Kubo, Tomoyo, Nishikubo, Masashi, Okada, Naoki, Kamijo, Kimimori, Yamamoto, Ryusuke, Nagai, Yuya, Hiramoto, Nobuhiro, Yoshioka, Satoshi, Yonetani, Noboru, Ishikawa, Takayuki

“…Background Cytomegalovirus reactivation (CMV-R) is a significant complication of allogeneic hematopoietic stem cell transplantation (allo-HCT), especially in…”
Get full text

Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation by Kamijo, Kimimori, Shimomura, Yoshimitsu, Kim, Sung‐Won, Ohigashi, Hiroyuki, Ishikawa, Jun, Eto, Tetsuya, Hiramoto, Nobuhiro, Mizuno, Ishikazu, Iida, Shinsuke, Ueda, Yasunori, Matsuoka, Ken‐ichi, Yakushijin, Kimikazu, Mori, Yasuo, Onizuka, Makoto, Fukuda, Takahiro, Atsuta, Yoshiko, Kako, Shinichi

“…Summary Reduced‐intensity conditioning regimens are commonly used in allogeneic haematopoietic cell transplantation for non‐Hodgkin lymphoma (NHL); however,…”
Get full text

Tumor lysis syndrome followed by tumor regression after COVID-19 in a patient with chronic lymphocytic leukemia by Yasumi, Masato, Yamamoto, Yudai, Kamijo, Kimimori, Kamae, Tsuyoshi, Yamato, Masaya, Karasuno, Takahiro

“…Coronavirus disease 2019 (COVID-19) can become lethal in patients with hematological malignancies; however, several cases of tumor regression after COVID-19…”
Get full text

Humoral response and safety of the BNT162b2 and mRNA‐1273 COVID‐19 vaccines in patients with haematological diseases treated with anti‐CD20 antibodies: An observational study by Nishikubo, Masashi, Shimomura, Yoshimitsu, Maruoka, Hayato, Nasu, Seiko, Nishioka, Tomomi, Sakizono, Kenji, Mitsuyuki, Satoshi, Kubo, Tomoyo, Okada, Naoki, Nakagawa, Daishi, Kamijo, Kimimori, Imoto, Hiroharu, Yamamoto, Ryusuke, Nagai, Yuya, Hiramoto, Nobuhiro, Yoshioka, Satoshi, Yonetani, Noboru, Matsushita, Akiko, Miyakoshi, Chisato, Doi, Asako, Ishikawa, Takayuki

Get full text

Trajectories of the SARS‐CoV‐2 RNA load in patients with hematological malignancy by Mitsuyuki, Satoshi, Nishikubo, Masashi, Shimomura, Yoshimitsu, Ohyama, Yukie, Maruoka, Hayato, Nasu, Seiko, Kubo, Tomoyo, Suzuki, Yuta, Okada, Naoki, Nakagawa, Daishi, Kamijo, Kimimori, Yamamoto, Ryusuke, Nagai, Yuya, Hiramoto, Nobuhiro, Yoshioka, Satoshi, Yonetani, Noboru, Hasegawa, Kohei, Kuroda, Hirokazu, Hasuike, Toshikazu, Doi, Asako, Kondo, Tadakazu, Ishikawa, Takayuki

“…Objectives The higher risk of prolonged viral shedding in coronavirus disease (COVID‐19) patients with hematological malignancies (HM) necessitates test‐based…”
Get full text

Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation by Kamijo, Kimimori, Shimomura, Yoshimitsu, Shinohara, Akihito, Mizuno, Shohei, Kanaya, Minoru, Usui, Yoshiaki, Kim, Sung-Won, Ara, Takahide, Mizuno, Ishikazu, Kuriyama, Takuro, Nakazawa, Hideyuki, Matsuoka, Ken-ichi, Kusumoto, Shigeru, Maseki, Nobuo, Yamaguchi, Masaki, Ashida, Takashi, Onizuka, Makoto, Fukuda, Takahiro, Atsuta, Yoshiko, Kondo, Eisei

“…   Allogeneic hematopoietic cell transplantation (HCT) offers a possible cure for patients with relapsed and refractory non-Hodgkin lymphoma (NHL) through…”
Get full text

A Case of Tyrosine Kinase Inhibitor-Induced Bone Marrow Aplasia That Was Successfully Treated with Allogeneic Hematopoietic Stem Cell Transplantation by Kamijo, Kimimori, Shimomura, Yoshimitsu, Yamashita, Daisuke, Ishikawa, Takayuki

Get full text